Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Description

Randomized comparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment of biopsy proven squamous cell carcinomas of the skin in otherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Conditions

Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer, Non-melanoma Skin Cancer

Study Overview

Study Details

Study overview

Randomized comparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment of biopsy proven squamous cell carcinomas of the skin in otherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Concentrated Ascorbic Acid in DMSO for Treatment of Squamous Cell Carcinoma of the Skin

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Condition
Squamous Cell Cancer
Intervention / Treatment

-

Contacts and Locations

Boise

Center for Biomedical Research,Inc., Boise, Idaho, United States, 83706

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 85 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Center for Biomedical Research, Inc.,

    Study Record Dates

    2024-12-31